Open AccessPharmacy and Therapeutics Committee Preparedness Plan for COVID-19
Author(s) -
Laila Carolina Abu Esba,
Hana Alabdulkarim,
Ahmed Alrushidan,
Mohammed Al Harbi
Publication year - 2020
Publication title -
global journal on quality and safety in healthcare
Language(s) - English
Resource type - Journals
eISSN - 2666-2353
pISSN - 2589-9449
DOI - 10.36401/jqsh-20-9
Subject(s) - preparedness , pharmacy , pandemic , covid-19 , medicine , advisory committee , family medicine , disease , infectious disease (medical specialty) , political science , pathology , public administration , law
As the Pharmacy and Therapeutics (P&T) committee acts as an advisory committee on therapeutic options, it is important during pandemics, such as the current Coronavirus disease 2019 pandemic, to quickly search the evidence, be able to select the most appropriate therapies despite the limited evidence, and make appropriate decisions related to which drugs to procure and stock. Potential therapies and recommendations to the P&T committee at a large healthcare institution as means of a preparedness plan are reviewed here.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom